ArticleInternational archives of allergy and immunology2026
Omalizumab for Injection (Enyitan®) in Elderly Patients with Chronic Spontaneous Urticaria: Maintenance of Treatment Goals - A 6-Month Retrospective Follow-Up of Real-World Evidence.
Lei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.